Major therapeutic advances and new perspectives in onco-hematology

被引：7

作者：

Bay, Jacques-Olivier ^{[1
,2
]}

Guieze, Romain ^{[1
,2
]}

Ravinet, Aurelie ^{[1
]}

Lemal, Richard ^{[1
]}

Xhaard, Alienor ^{[3
]}

Bailly, Sebastien ^{[1
]}

Molucon-Chabrot, Cecile ^{[1
]}

Hermet, Eric ^{[1
]}

Biau, Julian ^{[4
]}

Verrelle, Pierre ^{[4
]}

de latour, Regis Peffault ^{[3
]}

Tournilhac, Olivier ^{[1
,2
]}

机构：

[1] CHU Clermont Ferrand, Serv Hematol Clin Adulte & Therapie Cellulaire, F-63003 Clermont Ferrand 01, France

[2] Univ Auvergne, EA7283, CIC501, F-63000 Clermont Ferrand, France

[3] Hop St Louis, Serv Hematol Greffe, F-75010 Paris, France

[4] Ctr Jean Perrin, Serv Radiotherapie, F-63000 Clermont Ferrand, France

来源：

BULLETIN DU CANCER | 2013年 / 100卷 / 06期

关键词：

cancer; chemotherapy; targeted therapies; allo-graft; perspective; retrospective; CHRONIC LYMPHOCYTIC-LEUKEMIA; EXTENDED-FIELD RADIOTHERAPY; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; ABL TYROSINE KINASE; HODGKINS-LYMPHOMA; COMBINATION CHEMOTHERAPY; RADIATION-THERAPY; BODY IRRADIATION;

D O I：

10.1684/bdc.2013.1751

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hematology Oncology has a rich history including few crucial therapeutic innovations. These were possible because of the evolution of the cell and molecular biology allowing a better understanding of basic mechanisms of cancerogenesis. We propose here to summarize the most important therapeutic innovations since the beginning of Hematology/Oncology history. We also describe evolution of therapeutic strategies themselves. New insights and therapeutic perspectives for next future are also discussed.

引用

页码：587 / 599

页数：13

共 92 条

[21] Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].

Cornely, Oliver A. ;

Maertens, Johan ;

Winston, Drew J. ;

Perfect, John ;

Ullmann, Andrew J. ;

Walsh, Thomas J. ;

Helfgott, David ;

Holowiecki, Jerzy ;

Stockelberg, Dick ;

Goh, Yeow-Tee ;

Petrini, Mario ;

Hardalo, Cathy ;

Suresh, Ramachandran ;

Angulo-Gonzalez, David .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359

[22]

DAUSSET J., 1958, ACTA HAEMATOL, V20, P156

[23] COMBINATION CHEMOTHERAPY IN TREATMENT OF ADVANCED HODGKINS DISEASE [J].

DEVITA, VT ;

SERPICK, AA ;

CARBONE, PP .

ANNALS OF INTERNAL MEDICINE, 1970, 73 (06) :881-+

[24] Chlorambucil in indolent chronic lymphocytic leukemia [J].

Dighiero, G ;

Maloum, K ;

Desablens, B ;

Cazin, B ;

Navarro, M ;

Leblay, R ;

Leporrier, M ;

Jaubert, J ;

Lepeu, G ;

Dreyfus, B ;

Binet, JL ;

Travade, P ;

Turpin, FL ;

Tertian, G ;

Bichoffe, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1506-1514

[25] Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing [J].

Ding, Li ;

Ley, Timothy J. ;

Larson, David E. ;

Miller, Christopher A. ;

Koboldt, Daniel C. ;

Welch, John S. ;

Ritchey, Julie K. ;

Young, Margaret A. ;

Lamprecht, Tamara ;

McLellan, Michael D. ;

McMichael, Joshua F. ;

Wallis, John W. ;

Lu, Charles ;

Shen, Dong ;

Harris, Christopher C. ;

Dooling, David J. ;

Fulton, Robert S. ;

Fulton, Lucinda L. ;

Chen, Ken ;

Schmidt, Heather ;

Kalicki-Veizer, Joelle ;

Magrini, Vincent J. ;

Cook, Lisa ;

McGrath, Sean D. ;

Vickery, Tammi L. ;

Wendl, Michael C. ;

Heath, Sharon ;

Watson, Mark A. ;

Link, Daniel C. ;

Tomasson, Michael H. ;

Shannon, William D. ;

Payton, Jacqueline E. ;

Kulkarni, Shashikant ;

Westervelt, Peter ;

Walter, Matthew J. ;

Graubert, Timothy A. ;

Mardis, Elaine R. ;

Wilson, Richard K. ;

DiPersio, John F. .

NATURE, 2012, 481 (7382) :506-510

[26] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J].

Doehner, Hartmut ;

Estey, Elihu H. ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Burnett, Alan K. ;

Dombret, Herve ;

Fenaux, Pierre ;

Grimwade, David ;

Larson, Richard A. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel A. ;

Sierra, Jorge ;

Tallman, Martin S. ;

Loewenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2010, 115 (03) :453-474

[27] Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review [J].

dos Santos, Lucas Vieira ;

Souza, Fabiano Hahn ;

Brunetto, Andre Tesainer ;

Sasse, Andre Deeke ;

da Silveira Nogueira Lima, Joao Paulo .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (17) :1280-1292

[28] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].

Druker, BJ ;

Tamura, S ;

Buchdunger, E ;

Ohno, S ;

Segal, GM ;

Fanning, S ;

Zimmermann, J ;

Lydon, NB .

NATURE MEDICINE, 1996, 2 (05) :561-566

[29] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[30] Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group [J].

Engert, A ;

Schiller, P ;

Josting, A ;

Herrmann, R ;

Koch, P ;

Sieber, M ;

Boissevain, F ;

de Wit, M ;

Mezger, J ;

Dühmke, E ;

Willich, N ;

Müller, RP ;

Schmidt, BF ;

Renner, H ;

Müller-Hermelink, HK ;

Pfistner, B ;

Wolf, J ;

Hasenclever, D ;

Löffler, M ;

Diehl, V .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3601-3608

← 1 2 3 4 5 6 7 8 9 10 →